Association of a Single-Nucleotide Variant rs11100494 of the NPY5R Gene with Antipsychotic-Induced Metabolic Disorders

Background: The usage of antipsychotics (APs) is the most robust and scientifically based approach in the treatment of schizophrenia spectrum disorders (SSDs). The efficiency of APs is based on a range of target receptors of the central nervous system (CNS): serotoninergic, dopaminergic, adrenergic,...

Descripción completa

Detalles Bibliográficos
Autores principales: Dobrodeeva, Vera S., Shnayder, Natalia A., Novitsky, Maxim A., Asadullin, Azat R., Vaiman, Elena E., Petrova, Marina M., Limankin, Oleg V., Neznanov, Nikolay G., Garganeeva, Natalia P., Nasyrova, Regina F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876767/
https://www.ncbi.nlm.nih.gov/pubmed/35213955
http://dx.doi.org/10.3390/pharmaceutics14020222

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876767/
https://www.ncbi.nlm.nih.gov/pubmed/35213955
http://dx.doi.org/10.3390/pharmaceutics14020222

Ejemplares similares